January 16, 2013 at 07:33 AM EST
Sihuan Pharma Gains OK for Opioid Inhibitor
Sihuan Pharmaceutical Holdings received SFDA approval to begin producing Nalmefene Hydrochloride, a generic version of the “next generation” opioid receptor inhibitor Naloxone/Naltrexone. Nalmefene hydrochloride is used to counteract opioid overdose and to protect from drug relapse. Sihuan said the drug is also effective for treating heart failure, spinal cord injuries and cerebral protection following stroke. Sihuan Pharma specializes in cardio-cerebral vascular drugs. More details.... Stock Symbol: (HK: 0460) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here